Navigation Links
Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
Date:2/4/2013

PASADENA, Calif., Feb. 4, 2013 /PRNewswire/ -- CSNNewswire/Immunotech Laboratories, Inc. (PINKSHEETS:IMMB)

Company Director Mr. Bo. Linton of Immunotech Laboratories, Inc, a  Pasadena California based publicly traded company with patented "IPF" Technology  today stated Immunotech's technology  is now considered a major contender in the race for HIV & Cancer cures.  Recent information provided by the company for clinical testing results in both the HIV and Cancer sectors for terminal (Salvage) patients showed the use of the company's patented "IPF" vaccine treatments significantly reduced the number of infected cells while leaving the non infected cells in tact, and almost immediately started the regeneration of the body's natural immune system.

Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug".  If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company.  In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

About Immunotech Laboratories

Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and AIDS. Immunotech is committed to creating drugs for the better health of mankind.  Please visit Immunotechlab.com for information regarding the companies patented treatments, valuations and goals.

Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Immunotech Laboratories, Inc. from time to time in its periodic reports filed with the SEC. IPF is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Immunotech Laboratories believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Immunotech Laboratories to establish the efficacy of IPF in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of IPF in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, Immunotech Laboratories or any other person that the objectives and plans of Immunotech Laboratories will be achieved should not regard the forward-looking statements as a representation.

Immunotech Contact
ir@immunotechlab.com

Investor Relations:
The Nabors Group: 713-875-9200
E-mail: naborsgroup@yahoo.com
www.facebook.com/Naborsgroup


'/>"/>
SOURCE Immunotech Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
2. Nelson Laboratories to Host Free Educational Device Testing Classes at 2013 MD&M West Show
3. Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
4. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
5. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
6. New Jensen Dental White Paper Reveals How Dental Laboratories Can Increase Productivity, Profitability with a Multi-Function Pressing Furnace
7. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
8. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
9. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
10. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
11. Nelson Laboratories to Present Cleaning Validation Guidelines at BIOMEDevice San Jose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... Aug. 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... and big data solutions, today announced that it will ... 14 and host a conference call at 9:00am ET. ... and financial results and its strategy and outlook for ... by Erez Raphael , Chief Executive Officer, and ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... DUBLIN , Aug. 7, 2017  Endo International ... has reached agreements to resolve virtually all known U.S. ... in discussions to resolve the known remaining U.S. claims ... installment payments beginning in the fourth quarter of 2017 ... part of its second quarter 2017 results, the Company ...
Breaking Medicine Technology:
(Date:8/22/2017)... , ... August 22, 2017 , ... “Call Of Spiritual ... is the creation of published author, C.S. Lizarde. Growing up on the streets ... trials. When Carlos began to apply the Biblical keys to his life, he ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... ... but not without risk to health and safety. By learning and implementing best ... eliminated. , In this webinar, attendees will gain a better understanding of ...
(Date:8/21/2017)... ... August 21, 2017 , ... FCPX LUT Monochromatic Volume ... can quickly and easily add washed color grades to footage. A LUT is a ... every pixel’s color to the corresponding color indicated by the table. This pack comes ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... taking place all over the country. , Outdoor running increases exposure to ultraviolet ... at an increased risk of melanoma, and only half may be adequately protecting ...
(Date:8/21/2017)... ... August 21, 2017 , ... PIXACORE , an independent full-service agency with ... 100 agencies of the year by MM&M. , This is the first time PIXACORE ... milestone for the agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth ...
Breaking Medicine News(10 mins):